tiprankstipranks
Legend Biotech Corporation (LEGN)
NASDAQ:LEGN
US Market
LEGN
Legend Biotech
RESEARCH TOOLSreports

Legend Biotech (LEGN) Income Statement

653 Followers

Legend Biotech Income Statement

Last quarter (Q4 2025), Legend Biotech's total revenue was $307.64M, an increase of 64.93% from the same quarter last year. In Q4, Legend Biotech's net income was $-31.03M. See Legend Biotech’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 1.03B$ 627.24M$ 285.14M$ 117.00M$ 68.83M
Gross Profit
$ 622.44M$ 392.66M$ 140.93M$ 51.64M$ 68.83M
Operating Expenses
$ 759.30M$ 695.90M$ 580.41M$ 507.26M$ 461.11M
Depreciation and Amortization
$ 29.08M$ 23.36M$ 20.45M$ 18.39M$ 13.92M
EBITDA
$ -107.78M$ -113.16M$ -477.87M$ -416.54M$ -392.38M
Operating Income
$ -136.86M$ -303.24M$ -439.49M$ -455.62M$ -392.29M
Other Income/Expenses
$ -146.49M$ 145.11M$ -80.63M$ 9.90M$ -14.91M
Pretax Income
$ -283.35M$ -158.13M$ -520.12M$ -445.72M$ -407.20M
Net Income
$ -297.58M$ -177.03M$ -518.25M$ -446.35M$ -403.58M
Per Share Metrics
Basic EPS
$ -1.60$ -0.97$ -2.94$ -2.81$ -2.74
Diluted EPS
$ -1.60$ -0.97$ -2.94$ -2.81$ -2.74
Weighted Average Shares Outstanding
 184.32M 182.85M 176.08M 159.04M 140.85M
Weighted Average Shares Outstanding (Diluted)
 184.32M 182.85M 176.08M 159.04M 140.85M
Currency in USD

Legend Biotech Earnings and Revenue History